Sana Biotechnology Stock News

Sana Biotechnology Inc (SANA) shares closed today at 1.3% above its 52 week low of $12.56, giving the company a market cap of $2B. The stock is currently down 17.8% year-to-date, down 63.8% over the past 12 months, and down 63.8% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 2.6% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 8.7% lower than its 5-day moving average, 19.0% lower than its 20-day moving average, and 36.5% lower than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 1020.8% The company's stock price performance over the past 12 months lags the peer average by 106.9% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

SEATTLE, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, today announced that it will webcast it

Sana Biotechnology Inc (SANA) shares closed today at 0.6% above its 52 week low of $15.09, giving the company a market cap of $2B. The stock is currently down 56.8% year-to-date, down 56.8% over the past 12 months, and down 56.8% over the past five years. This week, the Dow Jones Industrial Average rose 3.9%, and the S&P 500 rose 4.9%. Trading Activity Trading volume this week was 51.6% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 90.9% The company's stock price performance over the past 12 months lags the peer average by 81.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Sana Biotechnology Inc (SANA) shares closed 0.1% lower than its previous 52 week low, giving the company a market cap of $3B. The stock is currently down 53.3% year-to-date, down 53.3% over the past 12 months, and down 53.3% over the past five years. This week, the Dow Jones Industrial Average rose 1.6%, and the S&P 500 rose 2.3%. Trading Activity Trading volume this week was 17.9% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 86.0% The company's stock price performance over the past 12 months lags the peer average by 76.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Sana Biotechnology, Inc. (NASDAQ:SANA)s share price gapped up before the market opened on Monday . The stock had previously closed at $17.65, but opened at $18.99. Sana Biotechnology shares last traded at $18.34, with a volume of 2,080 shares traded. The company has a market capitalization of $3.16 billion and a PE ratio of -1.80. []

Sana Biotechnology, Inc. (NASDAQ:SANA) reached a new 52-week low during trading on Monday . The stock traded as low as $16.00 and last traded at $16.00, with a volume of 33167 shares traded. The stock had previously closed at $16.67. Separately, Zacks Investment Research downgraded Sana Biotechnology from a hold rating to a sell rating []

Pluristem Therapeutics (NASDAQ:PSTI) and Sana Biotechnology (NASDAQ:SANA) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, earnings, dividends and profitability. Analyst Ratings This is a summary of current ratings and recommmendations for Pluristem Therapeutics and Sana []

Sana Biotechnology Inc. (NASDAQ:SANA) has seen 1.03 million shares traded in the last trading session. The company, currently valued at $3.53B, closed the last trade at $19.01 per share which meant it gained $1.24 on the day or 6.98% during that session. The SANA stock price is -134.61% off its 52-week high price of $44.60 Sana Biotechnology Inc. (SANA) Looks Set To Grow At A Great Clip In 2021 Read More »

Sana Biotechnology, Inc. (NASDAQ:SANA)’s share price gapped down prior to trading on Monday . The stock had previously closed at $21.31, but opened at $20.50. Sana Biotechnology shares last traded at $20.43, with a volume of 26 shares trading hands. A number of brokerages have weighed in on SANA. Zacks Investment Research lowered shares of […]

Tarbox Family Office Inc. reduced its position in Sana Biotechnology, Inc. (NASDAQ:SANA) by 33.3% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,000 shares of the companys stock after selling 1,000 shares during the quarter. Tarbox Family Office Inc.s holdings in Sana Biotechnology []

Sana Biotechnology (NASDAQ:SANA) and Beam Therapeutics (NASDAQ:BEAM) are both mid-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, analyst recommendations and risk. Earnings & Valuation This table compares Sana Biotechnology and Beam Therapeutics revenue, earnings per share []

Price T Rowe Associates Inc. MD reduced its stake in Sana Biotechnology, Inc. (NASDAQ:SANA) by 1.4% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 1,190,199 shares of the companys stock after selling 16,511 shares during the period. Price T Rowe Associates Inc. MDs holdings in Sana Biotechnology were worth $23,399,000 at the []

SEATTLE, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, today announced that data will be presen

Sana Biotechnology has a new $50 million tool in its toolbox.

Agreement combines Beam's gene editing technology with Sana's ex vivo platform